Kinetic Radical-scavenging Activity of Melatonin

0 downloads 0 Views 201KB Size Report
The kinetics of the polymerization of MMA initiated by thermal decomposition of ... stoichiometric factor (n, the number of free radicals trapped by the antioxidant ...
in vivo 20: 215-220 (2006)

Kinetic Radical-scavenging Activity of Melatonin SEIICHIRO FUJISAWA1, YOSHINORI KADOMA2, MARIKO ISHIHARA1, KAZUTOSHI SHIBUYA1 and ICHIRO YOKOE3 1Meikai

University School of Dentistry, Sakado, Saitama 350-0283; of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo 101-0062; 3Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama 350-0295, Japan

2Institute

Abstract. Carbon-centred free radicals can be involved in damage to biological systems under hypoxic/anoxic conditions as well as in ischaemia/reperfusion injury. The antioxidant activities of melatonin against carbon-centred radicals are poorly understood. The aim of this study was to investigate the antioxidant properties of melatonin against carbon-centred radicals in a biomimetic model system consisting of growing methyl methacrylate (MMA) radicals (poly-MMA radicals, PMMAØ). The kinetics of the polymerization of MMA initiated by thermal decomposition of 2,2’-azobis(isobutyronitrile) (AIBN; RØ radical) or benzoyl peroxide (BPO; PhCOOØ radical) in the presence of melatonin were investigated by the induction period method under nearly anaerobic conditions. As melatonin concentrations increased, the length of the induction period (IP) increased, but for the BPO system the IP reached a plateau at a molar ratio of BPO to melatonin of 5:1, indicating that the oxidation of melatonin by PhCOOØ was limited. At low concentrations of melatonin, the stoichiometric factor (n, the number of free radicals trapped by the antioxidant moiety) for melatonin was approximately 2, but as the melatonin concentration increased the n value decreased markedly to 0.1. These observations suggest that melatonin may possess catalytic activity contributing to radical avoidance. The initial rate of polymerization (Rp) in the BPO system was markedly suppressed by high concentrations of melatonin, suggesting a strong interaction between oxidative end-products formed from melatonin and PMMAØ . Under conditions where n was about 2, the kinh values for melatonin in the BPO system and the AIBN system were 6.58x104 M-1s-1 and 2.49x103 M-1s-1, respectively. In the BPO system, the kinh of melatonin was of a similar magnitude to that of ·-tocopherol, whereas in the AIBN system the kinh of

Correspondence to: Prof. S. Fujisawa, Department of Diagnostic and Therapeutic Sciences, Meikai University School of Dentistry, Sakado, Saitama 350-0283, Japan. Tel/Fax: (81) 492 86 1712, email: [email protected] Key Words: Melatonin, antioxidants, carbon-centred radicals.

0258-851X/2006 $2.00+.40

melatonin was 100-fold greater than that of tocopherol. The present findings suggest that melatonin may be able to scavenge harmful carbon-centred radicals in vivo. The pineal hormone melatonin [compound 1] was previously found to be a potent free radical scavenger that scavenges a variety of reactive oxygen species (ROS) including the hydroxy radical, hydrogen peroxide, singlet oxygen, nitric oxide and the peroxynitric anion (1-6). Melatonin also scavenges peroxy radicals derived from an azoinitiator (7) and lipid peroxy radicals (8). Ischaemia/reperfusion is a frequently encountered phenomenon in organisms. Prolonged ischaemia followed by reperfusion results in severe oxidative injury to tissues and organs. Carbon-centred free radicals can be involved in damage under hypoxic/anoxic conditions as well as in ischaemia/reperfusion injury. Melatonin plays an important role as a member of the antioxidant defense system that protects against potential oxidative injury induced by physiological ischaemia/reperfusion (9). However, the kinetics of the reaction of melatonin with carbon-centred radicals are virtually unknown. We have previously proposed a quantitative model rationalizing the radical-scavenging activity of phenolic compounds such as butylated hydroxytoluene-related compounds in polymerization of methyl methacrylate (MMA) initiated by thermal decomposition of 2,2’azobis(isobutyronitrile) (AIBN) or benzoyl peroxide (BPO) under nearly anaerobic conditions (10). The model was well able to explain the mechanism of radical-scavenging activity and to predict the chain-breaking activity of bioactive agents such as the polyamines (11), ‚-carotenes (12), oestrogens (13), ebselen (14), vitamin E (15) and diphenylamine-related compounds (16). The advantage of this model system is that measurements using a differential scanning calorimeter (DSC) are highly sensitive; furthermore, the use of anaerobic conditions makes this system relatively biomimetic, since oxygen is sparse in living cells (17). In the present study, the investigation was extended to melatonin, reporting kinetic studies of the radical-scavenging activity of melatonin.

215

in vivo 20: 215-220 (2006)

Figure 1. Time-conversion curves for polymerization of MMA 9.4 M at 70ÆC initiated by BPO (1 mol%) (A) or AIBN (1 mol%) (B) in the presence of 0, 0.001, 0.01, 0.1, 0.2, 0.5, 0.7 or 1.0 mol% melatonin.

Materials and Methods Melatonin was obtained from Tokyo Kasei Chem. Co., Tokyo, Japan. MMA (Tokyo Kasei Chem. Co.) was purified by distillation. AIBN and BPO (Tokyo Kasei Chem. Co.) were recrystallized from methanol and methanol/chloroform (1:1 v/v), respectively. Induction period and initial rate of polymerization. The induction period (IP) and initial rate of polymerization in the presence (Rpinh) or absence (Rpcon) of an antioxidant were determined by the method previously reported (10). In brief, the experimental resin consisted of MMA and AIBN (or BPO) with or without additive (melatonin). AIBN (or BPO) were added at 1.0 mol%, and melatonin was used at 0, 0.001, 0.01, 0.1, 0.2, 0.5, 0.7 and 1.0 mol%. Approximately 10 Ìl of the experimental resin (MMA: 9.12-9.96 mg) was loaded into an aluminum sample container and sealed by applying pressure. The container was placed in a differential scanning calorimeter (model DSC 3100; MAC Science Co., Tokyo, Japan) kept at 70ÆC, and the thermal changes induced by polymerization were recorded for the appropriate periods. The heat due to polymerization of MMA was 13.0 kcal/mole in this experiment. The conversion of samples, as calculated from the DSC thermograms, was 0-95%. Polymerization curves were derived from the DSC thermograms using the integrated heat evoked by the polymerization of MMA. Polymerization curves break when an inhibitor is consumed (Figure 1). These breaks are sharp and provide a reliable measure of the IP of the inhibitor. The presence of oxygen retards polymerization because oxygen reacts with MMA radicals activated by the initiator and then, subsequently, produces a nonradical product. Thus, polymerization of the control was slightly inhibited, even though the reaction was carried out in a sealed DSC pan, because the pan contained a small amount of oxygen, having been sealed in air. Tangents were drawn to polymerization curves at an early stage in the run. The IP of the test compounds was determined from the length of time between the zero point on the abscissa and the point of intersection of tangents drawn to the early stage of polymerization. The IP was calculated from the difference between the induction period of specimens and that of controls. The initial rates of polymerization in the absence

216

(Rpcon) and presence (Rpinh) of melatonin were calculated from the slope of the plots of the first linear line of the conversion rate of MMA polymerization (tangent drawn at the early polymerization stage). Measurement of stoichiometric factor (n). The relative n value in Eq. 1 can be calculated from the induction period in the presence of an inhibitor: 1 n = Ri[IP]/[IH] where [IP] is the induction period in the presence of an inhibitor and Ri is the rate of initiation. The number of moles of peroxy (or alkyl) radicals trapped by the antioxidant was calculated with respect to 1 mole of inhibitor moiety unit. The R i values of AIBN and BPO were 5.66x10 -6 Ms -1 and 2.28x10 -6 Ms -1, respectively (10). Measurement of inhibition rate constant (kinh). When Ri is constant, i.e., when new chains are started at a constant rate, a steady-state treatment can be applied and the initial rate of polymerization of MMA is given by Eq. 2 (10): 2 Rpcon = {kp[MMA] Ri1/2 }/(2kt)1/2 where MMA represents methyl methacrylate and kp and kt are the rate constants for chain propagation and termination, respectively. The kp/(2kt)1/2 rate of polymerization of MMA (9.4 M) initiated by AIBN (1 mol%) or BPO (1 mol%) at 70ÆC was a constant value, 9.86x10-2 M-1/2 s-1/2 (10). The Rpinh rates are determined by Eq. 3: 3 Rpinh = {kp [MMA] Ri}/{n kinh [IH]} in which Rpinh is the initial rate of inhibited polymerization, [MMA], n, [IH] and kp are defined above, and kinh is the rate constant for scavenging (inhibiting) of MMA radicals by an antioxidant. From Eq. 2 and Eq. 3, kinh/kp can be calculated (Eq. 4): 4 kinh/kp = [MMA]/{[IP]x[Rpinh]} The kinetic chain length (KCL) is given by Eq. 5. 5 KCL = Rpcon(or Rpinh)/Ri Computational details. Theoretical calculations of HOMO (highest occupied molecular orbital) and heats of formation were carried out by the semi-empirical molecular orbital (MO) method PM5, as implemented in the MOPAC program (Fujitsu CaChe 5.0).

Fujisawa et al: Antioxidant Properties of Melatonin

Figure 2. Plots of induction period (A), Rpinh/Rpcon (B) and conversion (C) versus concentrations of melatonin in the BPO and AIBN systems.

Results IP. Time-conversion curves for the BPO (A) and AIBN (B) systems in the presence of melatonin are shown in Figure 1. The concentration-effect curves for melatonin in the BPO and AIBN systems were clearly different. Values for IP, Rpinh/Rpcon and conversion were calculated from the curves, and the relationships between IP, Rpinh/Rpcon or conversion and concentration of melatonin are shown in Figures 2A, B and C, respectively. For the BPO system, the IP increased with increasing concentrations of melatonin, but reached a plateau at concentrations of 0.2 mol%. An IP value could not be calculated for the highest melatonin concentration (1.0 mol%) because polymerization did not occur, even after curing for 396 minutes. BPO (PhCOOOOCPh) decomposes into two benzoate radicals (PhCOOOOCPh → 2PhCOOØ) in the presence of MMA. Similarly, AIBN decomposes into two radicals ((CH3)2-CØ-C≡N). The observation that polymerization of MMA did not occur in an equimolar mixture of BPO and melatonin suggests that melatonin scavenges two PhCOOØ radicals. Although initiation by BPO may also occur via further decomposition (PhCOOØ → PhØ +CO2), such a decomposition has been well-known to preferably occur in the absence of methacrylates. The n values were calculated from Eq. 1 and are shown in Figure 2A. At low melatonin concentrations (0.001 mol%), the n value for both systems was about 2. As melatonin concentrations increased, the n values decreased, reaching about 0.1 at the highest concentration investigated.

concentration of 1.0 mol%, Rpinh/Rpcon was close to zero. In contrast, the Rpinh/Rpcon of melatonin for the AIBN system was about 1, similar to that of the control. The kinetic chain length (KCL) was calculated from Eq. 4. The KCL of the BPO system in the presence of 0, 0.1, 0.2, 0.5, 0.7 and 1.0 mol% melatonin was 611, 450, 386, 160, 139 and 0, respectively, whereas for the AIBN system the KCL was independent of the melatonin concentration and was almost constant, with values of 251-277. Melatonin oxidized by PhCOOØ markedly suppressed PMMAØ. The KCL of the control in the BPO system was twice that in the AIBN system, showing an inverse relationship to the corresponding Ri values. Conversion. In the BPO system, increasing concentrations of melatonin greatly decreased conversion (Figure 2C). In contrast, conversion in the AIBN system was not affected by the concentration of melatonin and was similar to that of the control. Melatonin oxidized by PhCOOØ acted as both an inhibitor and a retarder. In contrast, melatonin oxidized by RØ acted as an inhibitor alone. kinh. The kinh was calculated from Eq. 3. At a 1 to 0.001 molar ratio of initiator to melatonin, the kinh of melatonin for the AIBN and BPO systems was 6.58x104 M-1s-1 and 2.49x103 M-1s-1, respectively. (Note: kp is 405 M-1s-1 (14).) The kinh of melatonin for reaction with PMMAØ in the AIBN system was an order of magnitude greater than the corresponding value for the BPO system.

Discussion Rpcon/Rpinh. The results are shown in Figure 2B. The Rpinh/Rpcon of melatonin for the BPO system decreased as the melatonin concentration increased. At a melatonin

Since biological systems have low oxygen tensions (17), the effectiveness of antioxidants in vivo may be considerably

217

in vivo 20: 215-220 (2006) different from that in model systems. Many of the studies of the antioxidant activity of melatonin have been performed in the presence of oxygen (7, 8). Radicals can react with scavengers in different ways, by abstraction of an electron or a hydrogen atom, or by addition. For melatonin, radical addition has been observed or predicted theoretically only for interactions with hydroxy radicals (18) and nitric oxide (18, 19). Electron/hydrogen abstraction, however, may be a common mechanism for the interaction of melatonin with highly reactive oxidizing radicals such as PhCOOØ and RØ. Electron/hydrogen abstraction is a primary step of melatonin oxidation (Figure 3). The singlet transfer reaction of melatonin possibly plays a role in suppressing the reactivity of PhCOOØ and RØ under nearly anaerobic conditions. The ability of melatonin to scavenge PhCOOØ and RØ was decreased by increasing concentrations of melatonin, as reflected by the greatly decreased n value at high concentrations. This suggests that the antioxidant activity of melatonin depends on a balance of free radical concentration and quantity of melatonin. Melatonin showed antioxidant activity at low concentrations, but prooxidant activity at higher concentrations. A melatonin intermediate with melatonyl radicals (compound 3) may prevent further oxidation of other melatonin molecules, suggesting that melatonin possesses radical avoidance activity. In the present study, the radical-scavenging capacity of melatonin was evaluated in terms of both IP and Rp, allowing its activity to be represented as kinh. The kinh values of melatonin for the AIBN and BPO systems under conditions when n was about 2 were 6.58x104 M-1s-1 and 2.49x103 M-1s-1, respectively. The kinh values of ·-tocopherol for the AIBN and BPO systems, obtained by a method similar to that of the present study, were estimated to be 494 M-1s-1 and 6.08x103 M-1s-1, respectively (15). The scavenging activity of melatonin in the system initiated by AIBN was about 100-fold greater than that of ·-tocopherol. In contrast, the scavenging activity of melatonin in the system initiated by BPO was of a similar magnitude to that of ·-tocopherol. The radical-scavenging activity of melatonin was previously reported to be twice that of ·-tocopherol (20, 21). The radical-scavenging activity of melatonin with lipid peroxy radicals derived from radiation-induced oxidation of linoleate initiated by hydroxy radicals was previously reported to be 2.8x104 M-1s-1, suggesting that the antioxidant activity of melatonin-related compounds is related to their lipophilicity (8). In general, the destructive ability of carbon-centred radicals is underestimated because of their lower reactivity compared with that of hydroxy radicals. Nevertheless, aliphatic carbon-centred radicals are highly reactive in breaking supercoiled plasmid DNA (22). Carbon-centred free radicals can be involved in damage under hypoxic/anoxic conditions as well as in ischaemia/reperfusion injury.

218

Figure 3. A possible pathway of the one-electron transfer reaction of melatonin and heat of formation energies for its intermediates. PhCOOØ, benzoate radical derived from BPO; RØ, cyanoisopropyl radical derived from AIBN. Compound 1, melatonin.

Fujisawa et al: Antioxidant Properties of Melatonin

Melatonin was previously reported to be useful against ischaemia/reperfusion injury and has been shown to attenuate cardiac arrhythmias and to reduce oxidized lipids in the ischaemic heart (23). Whether lipid carbon-centred radicals generated from polyunsaturated fatty acids via chemical or enzymatic hydrogen abstraction are able to attack pathologically important targets remains to be clarified, but the present findings suggest that melatonin may be capable of scavenging such potentially harmful radicals. The antioxidant action of melatonin involves the donation of two electrons, not one electron, and melatonin (compound 1) scavenges two hydroxy radicals (3). One melatonin molecule has the potential to scavenge up to four or more reactive species (7). However, in the present study, the n value was 2 or less, suggesting the possibility of a singlet-electron transfer reaction in addition to a twoelectron transfer reaction. The chemistry of the interaction of melatonin with reactive species in the presence of oxygen has previously been reported (5). In the present study, the interaction of melatonin with the non-biological radicals PhCOOØ and RØ was examined to clarify the reaction pathway of melatonin. A PM5 method was used to estimate the mechanism of oxidation of melatonin by such non-biological radicals. The HOMO for melatonin is shown in Figure 3. Targeting sites for reaction exist in N2 (the highest density, 0.213) and in carbons C5 (0.170), C9 (0.163), C10 (0.143) and C12 (0.118). Possible reaction pathways with the target carbon atoms and the corresponding radical adducts for PhCOO Ø or RØ were identified by computational calculations, although indoleamine failed to act as an antioxidant. There are studies showing that compounds containing an NH group in a 5-membered pyrrole ring are not generally peroxy radical-trapping antioxidants (25, 26). Alkylperoxy and alkyl radicals are much more reactive, explaining why melatonin showed radical-scavenging activity in the present study. To further understand the antioxidant mechanism of melatonin, it would be of great interest to analyze melatonin oxidation end-products. Although we attempted to detect such end-products, we were unable to analyze them because of their very small quantity, suggesting that melatonin limits its own oxidation. Carboncentred radicals such as PMMAØ are scavenged by addition to oxygen or carbon. In the present study, melatonin reduced the KCL of the BPO system, indicating that the end-products formed by the reaction of melatonin with PhCOOØ could be targeted by PMMAØ . In contrast, melatonin did not affect the KCL of the AIBN system. This marked difference in the chain termination activity of melatonin between the AIBN and BPO systems suggests that different end-products of melatonin were formed by reaction with BPO or AIBN. Enzymatic and nonenzymatic reactions of melatonin with free radicals are

known (24). Apart from enzymatic metabolism, melatonin represents the most potent physiological scavenger of hydroxy radicals. The ability of melatonin to protect against hydroxy radical-induced carcinogenesis and neurodegeneration may be a significant part of the biological roles of this indoleamine (18, 25). The present findings extend these potential biological roles by suggesting that melatonin can react with and detoxify harmful carbon-centred radicals.

References 1 Hardeland R: Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27: 119-130, 2005. 2 Khaldy H, Escames G, Leon J, Vives F, Luna JD and AcunaCastroviejo D: Comparative effects of melatonin, L-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro. J Pineal Res 29: 100-1007, 2000. 3 Turjanski AG, Rosenstein RE and Estrin DA: Reactions of melatonin and related indoles with free radicals: a computational study. J Med Chem 41: 3684-3689, 1998. 4 Hardeland R: Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27: 119-130, 2005. 5 Allegra M, Reiter RJ, Tan D-X, Gentile L, Tesoriere L and Livrea MA: The chemistry of melatonin’s interaction with reactive species. J Pineal Res 34: 1-10, 2003. 6 Matuszak Z, Bilska MA, Reszka KJ, Chignell CF and Bilski P: Interaction of singlet molecular oxygen with melatonin and related indoles. Photochem Photobiol 78: 449-455, 2003. 7 Tan DX, Hardeland R, Manchester LC, Poeggeler B, LopezBurillo S, Mayo JC, Sainz RM and Reiter RJ: Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 34: 249-259, 2003. 8 Mekhloufi J, Bonnefont-Rousselot D, Yous S, Lesieur D, Couturier P, Therond P, Legrand A, Jore D and Gardes-Albert M: Antioxidant activity of melatonin and a pinoline derivative on linoleate model system. J Pineal Res 39: 27-33, 2005. 9 Tan DX, Manchester LC, Sainz RM, Mayo JC, Leon J and Reiter RJ: Physiological ischaemia/reperfusion phenomena and their relation to endogenous melatonin production: a hypothesis. Endocrine 27: 149-158, 2005. 10 Fujisawa S, Kadoma Y and Yokoe I: Radical-scavenging activity of butylated hydroxytoluene (BHT) and its metabolites. Chem Phys Lipids 130: 189-195, 2004. 11 Fujisawa S and Kadoma Y: Kinetic studies of the radicalscavenging activity of estrogens and antiestrogens. Anticancer Res 24: 3931-3937, 2004. 12 Fujisawa S, Ishihara M and Kadoma Y: Kinetics of the radical scavenging activity of beta-carotene-related compounds. SAR QSAR Environ Res 15: 33-41, 2004. 13 Fujisawa S and Kadoma Y: Kinetic evaluation of polyamines as radical scavengers. Anticancer Res 25: 965-969, 2005. 14 Fujisawa S and Kadoma Y: Kinetic studies of the radicalscavenging activity of ebselen, a seleno-organic compound. Anticancer Res 25: 3989-3994, 2005.

219

in vivo 20: 215-220 (2006) 15 Fujisawa S and Kadoma Y: Kinetic study of the radicalscavenging activity of vitamin E and ubiquinone. In Vivo 19: 1005-1011, 2005. 16 Fujisawa S, Ishihara M and Kadoma Y: Antioxidant activity of diphenylamine-related compounds as scavengers of carbon radicals. Internet Electron J Mol Des 4: 711-720, 2005. 17 Kessler M, Hoper J, Skolasinoka DK, Klovekorn WP, Sebening F, Volkholz HJ, Beier I, Kernbach C, Retting C and Richter H: Tissue O2 supply under normal and pathological conditions. Adv Exp Med Biol 169: 69-80, 1984. 18 Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M and Hardeland R: Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2: 181-197, 2002. 19 Turjanski AG, Saenz DA, Doctorovich F, Estrin DA and Rosenstein RE: Nitrosation of melatonin by nitric oxide: a computational study. J Pineal Res 31: 97-101, 2001. 20 Pieri C, Moroni F, Marra M, Marcheselli F and Recchioni R: Melatonin is an efficient antioxidant. Arch Gerontol Geriatr 20: 159-165, 1995. 21 Pieri C, Marra M, Moroni F, Recchioni R and Marcheselli F: Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55: 271-276, 1994.

220

22 Hiramoto K, Johkoh H, Sako K and Kikugawa K: DNA breaking activity of the carbon-centered radical generated from 2,2’-azobis(2-amidinopropane)hydrochloride (AAPH). Free Radic Res Commun 19: 323-332, 1993. 23 Reiter RJ and Tan DX: Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 58: 10-19, 2003 24 Livrea MA, Tesoriere L, D'Arpa D and Morreale M: Reaction of melatonin with lipoperoxyl radicals in phospholipid bilayers. Free Radic Biol Med 23: 706-711, 1997. 25 Antunes F, Barclay LR, Ingold KU, King M, Norris JQ, Scaiano JC and Xi F: On the antioxidant activity of melatonin. Free Radic Biol Med 26: 117-128, 1999. 26 Hardeland R, Reiter RJ, Poeggeler B and Tan DX: The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 17: 347-357, 1993.

Received November 28, 2005 Accepted February 1, 2006